In no other industry does the distribution of counterfeit products harm customers as much as in the pharmaceutical industry. Pharma brands must take proactive steps to stay ahead of criminals who counterfeit their drugs. Protection against the online distribution of suspicious medicinal products can be crucial. To look into the illegal use of pharma brands, Group-IB’s Digital Risk Protection team analyzed online sales of seven of the most common drugs produced by various manufacturers.

Join our webinar and listen to the discussion that unveils the investigation's main findings:

• Most often, fraudulent resources are disguised as websites belonging to ordinary pharmacies.
• Fraudsters sometimes buy dozens of domain names purporting to be those of a single pharmaceutical company.
• Bulletin boards can contain up to 2,500 offers per drug.